Viehbacher Christopher bought BIIB
February 13, 2026 · Form 4 insider transaction
Viehbacher Christopher bought 38,015 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,015
Price
$0.00
Total value
N/A
InsiderViehbacher Christopher
Role—
CompanyBiogen Inc. (BIIB)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after38,015
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.